Your browser doesn't support javascript.
loading
Identification of a Novel Inflamed Tumor Microenvironment Signature as a Predictive Biomarker of Bacillus Calmette-Guérin Immunotherapy in Non-Muscle-Invasive Bladder Cancer.
Damrauer, Jeffrey S; Roell, Kyle R; Smith, Markia A; Sun, Xuezheng; Kirk, Erin L; Hoadley, Katherine A; Benefield, Halei C; Iyer, Gopakumar; Solit, David B; Milowsky, Matthew I; Kim, William Y; Nielsen, Matthew E; Wobker, Sara E; Dalbagni, Guido; Al-Ahmadie, Hikmat A; Olshan, Andrew F; Bochner, Bernard H; Furberg, Helena; Troester, Melissa A; Pietzak, Eugene J.
Afiliación
  • Damrauer JS; University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina.
  • Roell KR; University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina.
  • Smith MA; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
  • Sun X; University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina.
  • Kirk EL; Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
  • Hoadley KA; University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina.
  • Benefield HC; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
  • Iyer G; University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina.
  • Solit DB; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
  • Milowsky MI; University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina.
  • Kim WY; Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
  • Nielsen ME; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
  • Wobker SE; Department of Medicine (Genitourinary Oncology Service), Memorial Sloan Kettering Cancer Center, New York, New York.
  • Dalbagni G; Department of Medicine, Weill Cornell Medicine, New York, New York.
  • Al-Ahmadie HA; Department of Medicine (Genitourinary Oncology Service), Memorial Sloan Kettering Cancer Center, New York, New York.
  • Olshan AF; Department of Medicine, Weill Cornell Medicine, New York, New York.
  • Bochner BH; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Furberg H; University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina.
  • Troester MA; Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
  • Pietzak EJ; University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina.
Clin Cancer Res ; 27(16): 4599-4609, 2021 08 15.
Article en En | MEDLINE | ID: mdl-34117034
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Vejiga Urinaria / Vacuna BCG / Adyuvantes Inmunológicos / Microambiente Tumoral / Transcriptoma Tipo de estudio: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Vejiga Urinaria / Vacuna BCG / Adyuvantes Inmunológicos / Microambiente Tumoral / Transcriptoma Tipo de estudio: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2021 Tipo del documento: Article